In HT-29 colon cancer cells, the expression of CD44+/CD133+/CD326+ was significantly higher for TS1 and TS2 in comparison to TR1, although only TS2 showed a significant increase in the proportion of cells with this phenotype when compared to the TP (Fig. 2E). This evidence concerns the gene CD44 and colonic neoplasm.